Navigation Links
Perrigo Announces Launch of Generic Version of Elestat®
Date:11/1/2011

ALLEGAN, Mich., Nov. 1, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its partner, PharmaForce/Luitpold Pharmaceuticals, received final approval for Epinastine HCl ophthalmic solution, 0.05%, a generic version of Elestat®. Perrigo will commence shipment of the product immediately.

Elestat® is a sterile ophthalmic solution containing epinastine that is indicated for the prevention of ocular itching associated with allergic conjunctivitis. Estimated annual brand sales for the product prior to generic market formation were $30 million, according to Wolters Kluwer data.

Perrigo's Chairman and CEO Joseph C. Papa stated, "Perrigo is excited to launch another new product in the ophthalmic category, as part of our extended topical strategy. This product is another example of Perrigo's commitment to expand our portfolio and bring new products to market. It further demonstrates our strategy to deliver quality affordable healthcare products."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology
2. Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
3. Perrigo Company Announces Quarterly Dividend
4. Perrigo Expands Infant Formula Distribution in China With Founder Group
5. Perrigo Company Will Release First Quarter Fiscal 2012 Results On October 27, 2011
6. Perrigo Company Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam
7. Perrigo to Host Analyst Day on October 5, 2011 at the TASE, Tel Aviv Stock Exchange in Tel Aviv, Israel
8. Perrigo to Host Analyst Day on September 27, 2011 at the NASDAQ MarketSite in Times Square
9. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
10. Perrigo Company Will Release Fourth Quarter Fiscal 2011 Results on August 16, 2011
11. Watson Enters into Agreement to Acquire Products Related to Perrigos Acquisition of Paddock Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015 For the pharmaceutical industry, marketplace success ... payers. Likewise, the importance of the managed markets function - ... to grow as payer formularies and provider networks play an ... At the same time, managed markets leaders must continually identify ...
(Date:1/23/2015)... 23, 2015 A lot of discussion in the medical ... certain illnesses, injuries, or conditions. As medical science advances, doctors ... with ones that they consider to be more cutting edge. ... one textbook method of treatment that stands out as the ...
(Date:1/23/2015)... analysis of Centers for Medicare and Medicaid Services, (CMS) ... percent of seniors chose lower-cost preferred pharmacy plans that ... The findings were released by Drug Channels . ... of Medicare Part D," said Pharmaceutical Care Management Association ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2No One-Size-Fits-All Remedy for Hernia Correction 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2
... Genetics announced today, at the American Society of ... its next generation Multiple Myeloma product, MyPRS Plus™, ... held predictive genetic testing company focused on oncology.  ... earlier product, which  effectively stratifies  Multiple Myeloma patients ...
... Incorporated (NYSE: DGX ), the world,s leading ... Care360™, the company,s electronic health platform, has been named ... Rankings, a leading source for accurate, impartial customer satisfaction ... Black Book Rankings surveyed over 70,000 healthcare IT ...
Cached Medicine Technology:Signal Genetics Announces Launch of Next Generation Genetic Multiple Myeloma Predictive Testing Product-MyPRS Plus™ 2Quest Diagnostics Care360™ Named Top e-Prescribing Platform by Black Book Rankings 2Quest Diagnostics Care360™ Named Top e-Prescribing Platform by Black Book Rankings 3
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
(Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
(Date:1/22/2015)... Ga., USA (PRWEB) January 22, 2015 ... a statewide data management system with support from GEOSYSTEMS, ... , The new solution will leverage Hexagon Geospatial’s ... and vector data as well as point clouds and ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... use of computer-aided detection (CAD) is increasing, in both screening ... issue of the Journal of the American College of Radiology ... radiologist of abnormal areas of density, mass or calcification on ... the presence of cancer. Screening mammography is ...
... 1, 2010 A UC Irvine infectious disease specialist has ... of new methods to prevent staph infections in people who ... The federal Agency for Healthcare Research & Quality awarded Huang ... funded by American Recovery & Reinvestment Act of 2009. CHOICE ...
... team led by investigators from Memorial Sloan-Kettering Cancer Center ... genetic changes that make some forms of glioblastoma, the ... than others and explains why they may not respond ... author Eric C. Holland, MD, PhD,--an MSKCC surgeon, researcher ...
... TWAS, the academy of sciences for the developing world, will ... October 2010. More than 350 scientists from 35 countries are ... India, will address the delegates at the opening ceremony. ... 2010 winner of the Ernesto Illy Trieste Science Prize and ...
... Oct. 1 issue of the journal Sleep found that ... associated with elevated blood pressure in the third trimester. The ... benefits. Results show that the mean systolic blood pressure in ... normal self-reported nightly sleep duration of nine hours in early pregnancy, ...
... found treatment with rufinamide results in a significant reduction ... uncontrolled partial-onset seizures (POS). Details of this study are ... published by Wiley-Blackwell on behalf of the International League ... of the worldwide population according to the Centers for ...
Cached Medicine News:Health News:Computer-aided detection is increasingly being used in screening and diagnostic mammography 2Health News:UCI gets major funding to study ways of preventing drug-resistant staph infections 2Health News:Researchers discover genetic changes that make some forms of brain cancer more aggressive 2Health News:TWAS to meet in India 2Health News:Short and long sleep in early pregnancy linked to high blood pressure in the third trimester 2Health News:Short and long sleep in early pregnancy linked to high blood pressure in the third trimester 3Health News:Adjunctive rufinamide reduces refractory partial-onset seizures 2
... closed dilution nebulizer allows the clinician to deliver ... gas into the side port for precise high ... P31000N, for normal flow patients, delivers 8-12 lpm ... the side port. For your high flow needs, ...
... dose inhalers., ,ACE ensures prompt, effective ... Its versatile design allows it to be ... with an endotracheal airway or resuscitation bag ... also be used in conjunction with an ...
Rotary Piston Mini Nebulizer...
Rotary Piston Nebulizer...
Medicine Products: